Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test

被引:74
|
作者
Warnecke, Tobias [1 ]
Suttrup, Inga [1 ]
Schroeder, Jens B. [1 ]
Osada, Nani [2 ]
Oelenberg, Stephan [1 ]
Hamacher, Christina [1 ]
Suntrup, Sonja [1 ]
Dziewas, Rainer [1 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Munster, Dept Med Informat, Domagkstr 9, D-48149 Munster, Germany
关键词
Parkinson's disease; Dysphagia; Swallowing; FEES; Levodopa responsiveness; DOPAMINERGIC STIMULATION; SWALLOWING ABNORMALITIES; AGREEMENT; DIAGNOSIS; THERAPY;
D O I
10.1016/j.parkreldis.2016.04.034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is still controversially discussed whether central dopaminergic stimulation improves swallowing ability in Parkinson's disease (PD). We evaluated the effect of oral levodopa application on dysphagia in advanced PD patients with motor fluctuations. Methods: In 15 PD patients (mean age 71.93 +/- 8.29 years, mean disease duration 14.33 +/- 5.94 years) with oropharyngeal dysphagia and motor fluctuations endoscopic swallowing evaluation was performed in the off state and on state condition following a specifically developed protocol (FEES-levodopa-test). The respective dysphagia score covered three salient parameters, i.e. premature spillage, penetration/aspiration events and residues, each tested with liquid as well as semisolid and solid food consistencies. An improvement of >30% in this score indicated levodopa responsiveness of dysphagia. Measures were compared between the off-and on-state condition by using the Wilcoxon Test and marginal homogeneity test. Inter- and intrarater reliability was also investigated. Results: Severity of swallowing dysfunction in the off state varied widely. The lowest dysphagia score was 15 points (dysphagia without any aspiration risk). The highest dysphagia score was 84 points (dysphagia with aspiration of all consistencies). Seven patients showed a marked improvement of dysphagia in the on state condition. Eight PD patients did not respond. Inter- and intrarater reliability was excellent for all three subscales in the off state and on state conditions. Conclusions: A significant proportion of advanced PD patients with motor fluctuations and mild to moderate oropharyngeal dysphagia may demonstrate a clinically relevant improvement of swallowing after levodopa challenge. The FEES-levodopa-test is a reliable and sensitive tool to differentiate these responders from non-responders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [31] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
  • [32] Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease
    Hoy, Sheridan M.
    DRUGS, 2019, 79 (15) : 1709 - 1718
  • [33] Mucuna pruriens as adjunct therapy to levodopa in advanced Parkinson's disease
    Botello-Villagrana, Fernando
    Martinez-Ramirez, Daniel
    REVISTA MEXICANA DE NEUROCIENCIA, 2021, 22 (05): : 180 - 183
  • [34] Gait analysis in advanced Parkinson's disease - effect of levodopa and tolcapone
    Shan, DE
    Lee, SJ
    Chao, LY
    Yeh, SI
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2001, 28 (01) : 70 - 75
  • [35] Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease
    Horstink, MWIM
    Praamstra, P
    NEUROLOGY, 1998, 51 (02) : 649 - 649
  • [36] Initial experience with levodopa intestinal gel for advanced Parkinson's disease
    Cohen, O. S.
    Yahalom, G.
    Strauss, H.
    Faust-Socher, A.
    Lang, A.
    Lerman, S. F.
    Baer, S. Hassin
    MOVEMENT DISORDERS, 2014, 29 : S137 - S137
  • [37] Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson’s Disease
    Sheridan M. Hoy
    Drugs, 2019, 79 : 1709 - 1718
  • [38] Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase
    Ganga, Ganesvaran
    Alty, Jane E.
    Clissold, Benjamin G.
    McColl, Craig D.
    Reardon, Katrina A.
    Schiff, Mark
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2013, 28 (04) : 476 - 481
  • [39] The impact of dysphagia in Parkinson?s disease patients treated with levodopa/carbidopa intestinal gel
    Rinaldi, Domiziana
    Imbalzano, Gabriele
    Galli, Silvia
    Bianchini, Edoardo
    Ledda, Claudia
    De Carolis, Lanfranco
    Zibetti, Maurizio
    Lopiano, Leonardo
    Pontieri, Francesco Ernesto
    Artusi, Carlo Alberto
    PARKINSONISM & RELATED DISORDERS, 2023, 109
  • [40] Using saccades as an early test of levodopa treatment in Parkinson's Disease
    Lu, Z. J.
    Dillon, S.
    Zetegren, P.
    Brzezick, M.
    Kennard, C.
    FitzGerald, J.
    Antoniades, C.
    MOVEMENT DISORDERS, 2018, 33 : S468 - S469